Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

被引:0
|
作者
Hannah A. Blair
机构
[1] Springer,
来源
Drugs | 2018年 / 78卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The original article has been corrected.
引用
收藏
页码:1911 / 1911
相关论文
共 50 条
  • [21] Ultraviolet recall due to cytarabine chemotherapy for acute myeloid leukaemia
    Kuo, Dennis John
    Spies, Jeanie Marie
    Le Floch, Nathalie
    Wong, Victor
    BMJ CASE REPORTS, 2021, 14 (11)
  • [22] CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia
    Cafaro, Alessandro
    Giannini, Maria B.
    Silimbani, Paolo
    Cangini, Delia
    Masini, Carla
    Di Rora, Andrea Ghelli Luserna
    Simonetti, Giorgia
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 455 - 466
  • [23] DAUNORUBICIN IN ACUTE LEUKAEMIA
    SOUHAMI, RL
    PRANKERD, TA
    POSTGRADUATE MEDICAL JOURNAL, 1970, 46 (535) : 272 - &
  • [24] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
    Ikezoe, Takayuki
    Ando, Kiyoshi
    Onozawa, Masahiro
    Yamane, Takahisa
    Hosono, Naoko
    Morita, Yasuyoshi
    Kiguchi, Toru
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Matsubara, Keisuke
    Sugimoto, Saori
    Miyazaki, Yasushi
    Kizaki, Masahiro
    Akashi, Koichi
    CANCER SCIENCE, 2022, 113 (12) : 4258 - 4266
  • [25] Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes
    Kim, Miryoung
    Williams, Sherry
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (08) : 792 - 800
  • [26] Liposomal cytarabine and daunorubicin (CPX-351) for treatment of acute myeloid leukemia
    Ronson, Aaron
    Tvito, Ariella
    Rowe, Jacob M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (04): : 369 - 374
  • [27] Assessing Efficacy and Safety of Daunorubicin and Cytarabine Liposomal in Patients with Acute Myeloid Leukemia
    Rogers, Elizabeth
    Hibino, Maho
    Hunt, Rebecca Garcia
    Ellis, Leslie Renee
    Bhave, Rupali
    Howard, Dianna S.
    Lyerly, Susan
    Dralle, Sarah
    Manuel, Megan
    Pardee, Timothy S.
    Powell, Bayard L.
    BLOOD, 2019, 134
  • [28] DAT (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID-LEUKEMIA
    REES, JKH
    HAYHOE, FGJ
    LANCET, 1978, 1 (8078): : 1360 - 1361
  • [29] Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin plus Cytarabine with Daunorubicin plus Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia
    Wang, Jing
    Yang, Yong-Gong
    Zhou, Min
    Xu, Jing-Yan
    Zhang, Qi-Guo
    Zhou, Rong-Fu
    Chen, Bing
    Ouyang, Jian
    PLOS ONE, 2013, 8 (04):
  • [30] Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin
    Morris, Karen L.
    Adams, Julie A.
    Yin, John A. Liu
    LEUKEMIA RESEARCH, 2009, 33 (08) : 1096 - 1099